Literature DB >> 2271372

The effect of cholestyramine and activated charcoal on glipizide absorption.

K T Kivistö1, P J Neuvonen.   

Abstract

1. The interference of cholestyramine and activated charcoal with the absorption of glipizide was studied. 2. In a cross-over study comprising three phases, single doses of cholestyramine (8 g), activated charcoal (8 g) or water only were given to six healthy volunteers together with a single dose of glipizide. 3. The absorption of glipizide was moderately (29%, P less than 0.01) reduced by cholestyramine and greatly reduced (81%, P less than 0.01) by activated charcoal. 4. If cholestyramine and glipizide are used concomitantly, glipizide should be taken 1-2 h beforehand. In acute glipizide overdosage, activated charcoal can be used to reduce absorption.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2271372      PMCID: PMC1368174          DOI: 10.1111/j.1365-2125.1990.tb03843.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  Effects of resins and activated charcoal on the absorption of digoxin, carbamazepine and frusemide.

Authors:  P J Neuvonen; K Kivistö; E L Hirvisalo
Journal:  Br J Clin Pharmacol       Date:  1988-02       Impact factor: 4.335

Review 2.  The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs.

Authors:  R E Ferner; S Chaplin
Journal:  Clin Pharmacokinet       Date:  1987-06       Impact factor: 6.447

3.  High-performance liquid chromatographic determination of glipizide and some other sulfonylurea drugs in serum.

Authors:  E Wåhlin-Boll; A Melander
Journal:  J Chromatogr       Date:  1979-12-01

4.  Effect of cholestyramine and colestipol on the absorption of phenytoin.

Authors:  J T Callaghan; M Tsuru; J L Holtzman; D B Hunninghake
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

5.  Activated charcoal in the treatment of hypercholesterolaemia: dose-response relationships and comparison with cholestyramine.

Authors:  P J Neuvonen; P Kuusisto; H Vapaatalo; V Manninen
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

6.  Adsorption of sulfonylureas onto activated charcoal in vitro.

Authors:  H Kannisto; P J Neuvonen
Journal:  J Pharm Sci       Date:  1984-02       Impact factor: 3.534

7.  Enhanced elimination of warfarin during treatment with cholestyramine.

Authors:  E Jähnchen; T Meinertz; H J Gilfrich; F Kersting; U Groth
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

8.  Effects of charcoal, sodium bicarbonate, and ammonium chloride on chlorpropamide kinetics.

Authors:  P J Neuvonen; S Kärkkäinen
Journal:  Clin Pharmacol Ther       Date:  1983-03       Impact factor: 6.875

Review 9.  Oral activated charcoal in the treatment of intoxications. Role of single and repeated doses.

Authors:  P J Neuvonen; K T Olkkola
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Jan-Dec

10.  Effect of activated charcoal on absorption of tolbutamide and valproate in man.

Authors:  P J Neuvonen; H Kannisto; E L Hirvisalo
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

View more
  7 in total

1.  Concomitant administration of cholestyramine influences the absorption of troglitazone.

Authors:  M A Young; S Lettis; R Eastmond
Journal:  Br J Clin Pharmacol       Date:  1998-01       Impact factor: 4.335

Review 2.  Octreotide's role in the management of sulfonylurea-induced hypoglycemia.

Authors:  Patrick P Dougherty; Wendy Klein-Schwartz
Journal:  J Med Toxicol       Date:  2010-06

Review 3.  Antihyperlipidaemic agents. Drug interactions of clinical significance.

Authors:  J A Farmer; A M Gotto
Journal:  Drug Saf       Date:  1994-11       Impact factor: 5.606

4.  Role of colestipol in the treatment of hyperthyroidism.

Authors:  P Hagag; H Nissenbaum; M Weiss
Journal:  J Endocrinol Invest       Date:  1998-12       Impact factor: 4.256

Review 5.  Pharmacotherapy of type 2 diabetes mellitus: an update on drug-drug interactions.

Authors:  Muhammad Amin; Naeti Suksomboon
Journal:  Drug Saf       Date:  2014-11       Impact factor: 5.606

Review 6.  Treatment of sulfonylurea and insulin overdose.

Authors:  Wendy Klein-Schwartz; Gina L Stassinos; Geoffrey K Isbister
Journal:  Br J Clin Pharmacol       Date:  2016-01-06       Impact factor: 4.335

Review 7.  Antihyperglycaemic agents. Drug interactions of clinical importance.

Authors:  A J Scheen; P J Lefèbvre
Journal:  Drug Saf       Date:  1995-01       Impact factor: 5.606

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.